Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jan 11;7(1):e014259.
doi: 10.1136/bmjopen-2016-014259.

Cancer-related hospitalisations and 'unknown' stage prostate cancer: a population-based record linkage study

Affiliations

Cancer-related hospitalisations and 'unknown' stage prostate cancer: a population-based record linkage study

Qingwei Luo et al. BMJ Open. .

Abstract

Objectives: To identify reasons for prostate cancer stage being recorded as 'unknown' in Australia's largest population-based cancer registry.

Design: Prospective population-based cohort.

Setting: New South Wales (NSW) is the most populous state in Australia, with almost one third of the total national population.

Participants: NSW Cancer Registry (NSWCR) records for prostate cancer cases diagnosed in 2001-2009 were linked to the NSW Admitted Patient Data Collection (APDC) for 2000-2010. All patients in this study had a minimum of 12 months follow-up in the hospital episode records after their date of diagnosis as recorded by the NSWCR.

Main outcome measures: Incidence of 'unknown' stage prostate cancer and cancer-specific survival.

Results: Of 50 597 prostate cancer cases, 39.9% were recorded as having 'unknown' stage. Up to 4 months after diagnosis, 77.2% of cases without a hospital-reported cancer diagnosis were recorded as having 'unknown' stage. Among those patients with a hospital-reported cancer diagnosis, stage was 'unknown' for 7.6% of cases who received a radical prostatectomy (RP) and for 34.0% of cases who had procedures other than RP. In the latter group, the factors that were related to having 'unknown' stage were living in disadvantaged areas (adjusted OR (aOR) range: 1.13 to 1.20), attending a private hospital (aOR range: 1.25 to 2.13), having day-only admission for care (aOR=1.23, 95% CI 1.11 to 1.36), or having procedures other than multiple procedures with imaging (eg, biopsy only, aOR range: 1.11 to 1.45).

Conclusions: Over half of 'unknown' stage prostate cancer cases did not have a hospital-reported prostate cancer diagnosis within the 4 months after initial diagnosis. We identified differences in the likelihood of cases being recorded as 'unknown' stage based on socioeconomic status and facility type, which suggests that further investigation of reporting practices in relation to diagnostic and treatment pathways is required.

Keywords: data linkage; health service; population-based cancer registry; prostate cancer; socio-economic status; unknown stage at diagnosis.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None declared.

Figures

Figure1
Figure1
Diagnostic and initial treatment pathways for prostate cancer in New South Wales, Australia.
Figure 2
Figure 2
Distribution of men with ‘unknown’ stage at diagnosis by hospital-reported prostate cancer diagnosis and procedures, New South Wales, Australia, 2001–2009 (n=50 597).
Figure 3
Figure 3
Prostate cancer specific survival by stage at diagnosis recorded in the NSWCR stratified by cancer-related procedures, New South Wales, Australia, 2001–2008, followed up to the end of 2008 (n=43 368).
Figure 4
Figure 4
Associations between patients’ characteristics and ‘unknown’ stage prostate cancer for patients with a hospital-reported prostate cancer diagnosis and prostate procedures other than radical prostatectomy ≤4 months after diagnosis, New South Wales, Australia, 2001–2009 (n=19 864).

Similar articles

Cited by

References

    1. Yu XQ, O'Connell DL, Gibberd RW et al. . A population-based study from New South Wales, Australia 1996–2001: area variation in survival from colorectal cancer. Eur J Cancer 2005;41:2715–21. 10.1016/j.ejca.2005.05.018 - DOI - PubMed
    1. Yu XQ, Smith DP, Clements MS et al. . Projecting prevalence by stage of care for prostate cancer and estimating future health service needs: protocol for a modelling study. BMJ Open 2011;1:e000104 10.1136/bmjopen-2011-000104 - DOI - PMC - PubMed
    1. Klassen AC, Curriero F, Kulldorff M et al. . Missing stage and grade in Maryland prostate cancer surveillance data, 1992–1997. Am J Prev Med 2006;30(2 Suppl):S77–87. 10.1016/j.amepre.2005.09.010 - DOI - PubMed
    1. Luo Q, Yu XQ, Cooke-Yarborough C et al. . Characteristics of cases with unknown stage prostate cancer in a population-based cancer registry. Cancer Epidemiol 2013;37:813–19. 10.1016/j.canep.2013.09.008 - DOI - PubMed
    1. Yu XQ, O'Connell DL, Gibberd RW et al. . Trends in survival and excess risk of death after diagnosis of cancer in 1980–1996 in New South Wales, Australia. Int J Cancer 2006;119:894–900. 10.1002/ijc.21909 - DOI - PubMed

Publication types

LinkOut - more resources